ImmunoDx
Woburn, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $100M
Overview
A diagnostics firm creating immune-based tests for early cancer detection and monitoring.
OncologyImmunologyDiagnostics
Technology Platform
A diagnostic platform utilizing multiplex immunoassays and AI to profile the immune system's response for early cancer detection and therapy monitoring.
Funding History
1Total raised:$100M
Private Equity$100M
Opportunities
Growing demand for early detection and precision monitoring tools in oncology, especially with the rise of immunotherapies.
Risk Factors
Commercialization risk due to the challenges of clinical adoption, reimbursement, and competing against well-capitalized diagnostic giants.
Competitive Landscape
Faces intense competition in the oncology diagnostics market from large diagnostic firms and liquid biopsy companies, differentiating through an immunology-focused approach.